தொடர்பு கொள்ளக்கூடியது நோய் மையம் இல் ஹமாத் மருத்துவ நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தொடர்பு கொள்ளக்கூடியது நோய் மையம் இல் ஹமாத் மருத்துவ நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தொடர்பு கொள்ளக்கூடியது நோய் மையம் இல் ஹமாத் மருத்துவ நிறுவனம் Today - Breaking & Trending Today

Evidence supports the effectiveness of COVID-19 vaccines in Qatar: CDC Medical Director


Dr. Muna Al Maslamani, Medical Director of Communicable Disease Center at Hamad Medical Corporation, stated that there is clear evidence that the COVID-19 vaccines offer high levels of protection against the coronavirus and preventing people from getting sick in Qatar.
She explained that the Pfizer-BioNTech and Moderna vaccines have proven to be around 95 percent effective at preventing symptomatic infection during extensive clinical trials.
She added that this does not indicate that vaccinated individuals are immune to the virus or cannot contract it. However, vaccinated individuals are more unlikely to develop severe symptoms and become ill in the case of being COVID-19 positive. ....

Al Maslamani , Muna Al Maslamani , Communicable Disease Center At Hamad Medical Corporation , Medical Director , Communicable Disease Center , Hamad Medical Corporation , Ramadan Page , தொடர்பு கொள்ளக்கூடியது நோய் மையம் இல் ஹமாத் மருத்துவ நிறுவனம் , மருத்துவ இயக்குனர் , தொடர்பு கொள்ளக்கூடியது நோய் மையம் , ஹமாத் மருத்துவ நிறுவனம் ,

New medicine adopted for Covid-19 patients: HMC official


 17 Apr 2021 - 7:49
By Sanaullah Ataullah | The Peninsula
Doha: Medical Director of the Communicable Disease Center at Hamad Medical Corporation (HMC), Dr. Muna Al Maslamani, has said that new medicine has been adopted for COVID-19 infected people in emergency case.
“We adopted new medicine for COVID-19 patients. Only one doze of this medicine is being given to the infected people through their vein,” said Dr. Muna Al Maslamani in a video footage shared on HMC Twitter account.
She said that the new medicine has special standards. “The medicine is being given especially to those COVID-19 patients whose health condition is expected to be deteriorated by the time. So we give this medicine to them before deterioration of their health condition,” said Dr. Al Maslamani.  ....

Ad Daw Ah , Al Maslamani , Muna Al Maslamani , Communicable Disease Center At Hamad Medical Corporation , Communicable Disease Center , Medical Director , Hamad Medical Corporation , Covid 19 , தொடர்பு கொள்ளக்கூடியது நோய் மையம் இல் ஹமாத் மருத்துவ நிறுவனம் , தொடர்பு கொள்ளக்கூடியது நோய் மையம் , மருத்துவ இயக்குனர் , ஹமாத் மருத்துவ நிறுவனம் ,